Fulgent Genetics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	633	857	877	3,001	1,265	241	57	78	205
Market Cap Growth	-	-2.28%	-70.79%	137.28%	423.96%	321.38%	-26.63%	-61.83%	-
Enterprise Value	210	434	371	2,572	980	216	26	52	184
PE Ratio	-5.11	-5.11	6.11	5.91	5.90	-587.26	-10.22	-31.10	-38.25
PS Ratio	2.19	2.96	1.42	3.02	3.00	7.42	2.68	4.17	11.19
PB Ratio	0.56	0.75	0.69	2.59	2.22	2.92	1.12	1.44	3.75
P/FCF Ratio	113.56	153.78	3.73	5.83	11.99	55.68	-16.33	-19.39	326.18
P/OCF Ratio	23.43	31.73	3.46	5.57	8.99	43.75	-84.86	58.65	46.43
EV/Sales Ratio	0.72	1.50	0.60	2.59	2.32	6.63	1.23	2.75	10.05
EV/EBITDA Ratio	-3.23	-3.23	1.66	3.70	3.38	100.27	-7.70	-28.70	86.26
EV/EBIT Ratio	-2.60	-2.60	2.00	3.77	3.42	-586.33	-4.71	-14.63	191.50
EV/FCF Ratio	37.63	77.85	1.58	4.99	9.29	49.77	-7.48	-12.82	292.90
Debt / Equity Ratio	0.00	0.00	0.02	0.02	0.03	0.03	-	-	-
Debt / EBITDA Ratio	-0.01	-0.01	0.09	0.03	0.05	1.24	-	-	-
Debt / FCF Ratio	0.21	0.21	0.09	0.04	0.14	0.62	-	-	-
Quick Ratio	6.51	6.51	6.57	5.60	3.71	9.35	13.51	10.16	7.61
Current Ratio	6.96	6.96	7.13	5.81	4.02	9.96	14.44	10.98	7.88
Asset Turnover	0.22	0.22	0.43	0.88	1.49	0.50	0.39	0.32	0.57
Interest Coverage	-	-	-	-	-	-	-	-	0.18
Return on Equity (ROE)	-13.60%	-13.60%	11.10%	51.90%	92.70%	-0.70%	-10.70%	-4.60%	-17.90%
Return on Assets (ROA)	-12.60%	-12.60%	10.00%	44.80%	75.70%	-0.60%	-10.20%	-4.30%	-16.70%
Return on Capital (ROIC)	-17.19%	-17.19%	10.72%	42.60%	37.10%	-0.50%	-9.91%	-6.43%	1.69%
Earnings Yield	-26.53%	-19.59%	16.36%	16.91%	16.95%	-0.17%	-9.79%	-3.22%	-2.61%
FCF Yield	0.88%	0.65%	26.82%	17.16%	8.34%	1.80%	-6.12%	-5.16%	0.31%
Buyback Yield / Dilution	3.81%	3.81%	0.04%	-28.77%	-28.58%	-4.07%	-1.35%	-29.39%	-15.77%
Total Shareholder Return	3.81%	3.81%	0.04%	-28.77%	-28.58%	-4.07%	-1.35%	-29.39%	-15.77%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).